15.63CAD-4.58%Mkt Cap: 418.31M $P/E: —1d ago
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cispl…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap418.31M $
Enterprise Value369.12M $
Revenue (TTM)43.13M $
Gross Profit29.77M $
Net Income (TTM)-7.09M $
Revenue/Share1.345 USD
Last Price15.63 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees35
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA31447P1009
Valuation
P/E (Trailing)—
P/E (Forward)11.81
PEG—
EV/EBITDA-496.26
EV/Revenue8.56
P/S9.26
P/B9.30
EPS (TTM)-0.17
EPS (Forward)1.32
52W Range
7.59080% of range17.64
52W High17.64 CAD
52W Low7.590 CAD
Profitability
Gross Margin91.57%
Oper. Margin9.72%
EBITDA Margin-1.73%
Profit Margin-21.82%
ROE-27.46%
ROA-13.81%
Growth
Revenue Growth85.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.08M $
CapEx (TTM)—
FCF Margin1.81%
FCF Yield0.19%
Net Debt-30.04M $
Net Debt/EBITDA40.39
Balance Sheet
Debt/Equity0.00
Current Ratio5.85
Quick Ratio5.21
Book Value/Sh1.680 CAD
Cash/Share1.176 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3
Split DateSep 5, 2014
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.35.07M
Float19.78M
Insiders14.31%
Institutions54.32%
Short Interest
Short Ratio120.7d
Short % Float0.08%
Short % Out.0.07%
Shares Short24.62K
Short (prev mo.)24.67K
Technical
SMA 5014.66 (+6.6%)
SMA 20011.68 (+33.9%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)420
Avg Vol (10d)820
Technical Indicators
RSI (14)59.6
MACD0.6906
MACD Signal0.4772
MACD Hist.+0.2133
BB Upper17.54 CAD
BB Middle15.05 CAD
BB Lower12.55 CAD
BB Width33.19%
ATR (14)0.5020 CAD
Vol Ratio (20d)0.19x